Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus

Scandinavian Journal of Rheumatology

Volumn 28, Issue 6, 1999, Pages 344-351

  Sebastiani, Gian Domenico ^a   Galeazzi, Mauro ^j   Tincani, Angela ^b   Piette, Jean Charles ^c   Font, Josep ^d   Allegri, Flavio ^b   Mathieu, Alessandro ^k   Smolen, Josef ^e   De Ramon Garrido, Enrique ^f   Fernandez Nebro, Antonio ^g   Jedryka Goral, Anna ^k   Papasteriades, Chryssa ^h   Morozzi, Gabriella ^k   Bellisai, Francesca ^k   De Pita, Ornella ⁱ   Marcolongo, Roberto ^k  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SPEDALI CIVILI   (Italy)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HOSPITAL CLÍNIC   (Spain)

^e GENERAL HOSPITAL LINZ   (Austria)

^f UGC of Pharmacy   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h EVANGELISMOS HOSPITAL   (Greece)

ⁱ LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^j UNIVERSITY OF SIENA   (Italy)

^k NONE

more..

Author keywords

aCL; Antiphospholipid syndrome; a 2GPI; Systemic lupus erythematosus

Indexed keywords

BETA GLOBULIN; CARDIOLIPIN ANTIBODY; ALLOANTIBODY; BETA2 GLYCOPROTEIN 1; GLYCOPROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; CARDIOVASCULAR DISEASE; CLASSIFICATION; CLINICAL TRIAL; COMORBIDITY; EPIDEMIOLOGY; EUROPE; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; BETA 2-GLYCOPROTEIN I; CARDIOVASCULAR DISEASES; COMORBIDITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); EUROPE; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0033256156     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749950155328     Document Type: Article

References (40)

1. 1. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies. Detection by radioimmunoassay and association with thrombosis in SLE. Lancet 1983;ii:1211-4.
2. 2. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Antiphospholipid antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
3. 3. Hughes GRV. The antiphospholipid syndrome. Lupus 1996;5:345-6.
4. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
5. 5. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
6. 6. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(sand differential diagnosis of autoimmune disease (letter). Lancet 1990;336:177-8.
7. 2-glycoprotein I contains a phospholipid binding site (Cys 281-Cys 288) and a region recognized by anticardiolipin antibodies. J Immunol 1994;152:653-9.
8. 8. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992;148:3885-91.
9. 2-glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995;89:397-402.
10. 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995;4:122-30.
11. 11. Navarro M, Cervera R, Teixidò M, Reverter JC, Font J, Lòpez-Soto A, et al. Antibodies to endothelial cells and to b2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution. Br J Rheumatol 1996;35:523-8.
12. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466-74.
13. 13. Roubey RAS, Maldonado MA, Byrd SN. Comparison of an enzyme-linked immunosorbent assay for antibodies to b2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 1996;39:1606-7.
14. 14. Piette JC. 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible"? Lupus 1996;5:354-63.
15. 15. Alarcon-Segovia D, Cabral AR. The concept and classification of antiphospholipid/cofactor syndrome. Lupus 1996;5: 364-7.
16. 16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7.
17. 17. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 1993;72:113-24.
18. 18. Harris EN, Gharavi AE, Patel SP, Hughcs GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68: 215-22.
19. 2GPI in rat: isolation from serum and demonstration in lipoprotein density fraction. J Biochem 1980;11:265-70.
20. 20. La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden D, Lojacono A, et al. Beta 2 glycoprotein 1 and placental anticoagulant protein 1 in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684-93.
21. 21. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 1990;112:682-98.
22. 22. Roubey RAS, Maldonado MA, Byrd SN, Winfield JB. Elisa for autoantibodies to Beta2-glycoprotein I: comparison with a standard "anticardiolipin" assay. Arthritis Rheum 1994;37: S296 (abstract).
23. 23. Balestrieri G, Tincani A, Spatola L, et al. Anti-beta-2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995;4:122-30.
24. 24. Alarcon-Segovia D, Cabrai AR. Autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 1996;8:403-7.
25. 25. McNally T, Purdy G, Mackie IJ, Machin SJ, Isenberg DA. The use of an anti-beta-2-glycoprotein I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995;91:471-3.
26. 26. Faden D, Tincani A, Tanzi P, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta 2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:37-42.
27. 27. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize beta2-glycoprotein I structure altered by interacting with an oygen modified solid phase surface. J Exp Med 1994;179:457-62.
28. 28. Roubey RA, Eisenberg RA, Harper MF, Winfield JB. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995;154:954-60.
29. 29. Tincani A, Spatola L, Prati E, et al. The anti-beta-2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes locate on native beta-2-glycoprotein I and preserved during species' evolution. J Immunol 1996;157:5732-8.
30. 30. Sheng Y, Kandiah DA, Krilis SA. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity. J Immunol 1998;161:2038-43.
31. 31. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996;39:1444-54.
32. 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;93:181-6.
33. 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995;22:1899-906.
34. 34. Day TM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. Autoantobody to beta2-glicoprotein I in systemic lupus erythematosus and primary antiphospholipid antobody syndrome: clinical correlation in comparison with other antiphospholipid antibody tests. J Rheumatol 1998;25: 667-74.
35. 35. Horbach DA, van Oort E, Donders RCJM, Derksen RHWM, de Groot PG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996;76:916-24.
36. 36. Sammaritano L, Ng S, Sobel R, Lo SK, Simantov R, Furie R, et al. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arhtritis Rheum 1997;40:1998-2006.
37. 37. Peaceman AM, Silver RK, Mac Gregor SM, Socol ML. Interlaboratory variation in antiphospholipid antibody testing. Am J Obst Gynecol 1992;166:1780-7.
38. 38. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, et al. Multicenter evaluation of nine kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995;52:444-52.
39. 2-glycoprotein I: Preparation, properties and availability to investigators. Clin Chem 1996;42:1116-7.
40. 40. Alarcon-Segovia D, Mestanza M, Cabiedes Cabral A. The antiphospholipid/cofactor syndromes. A variant in patients with systemic lupus erithematosus with antibodies to β2GPI but no antibodies detectable in standard antiphospholipid assays. J Rheumatol 1997;24:1545-51.